These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8780834)

  • 1. Effects of antidepressants on intracellular Ca2+ mobilization in CHO cells transfected with the human 5-HT2C receptors.
    Akiyoshi J; Isogawa K; Yamada K; Nagayama H; Fujii I
    Biol Psychiatry; 1996 Jun; 39(12):1000-8. PubMed ID: 8780834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid desensitization of serotonin 5-HT2C receptor-stimulated intracellular calcium mobilization in CHO cells transfected with cloned human 5-HT2C receptors.
    Akiyoshi J; Nishizono A; Yamada K; Nagayama H; Mifune K; Fujii I
    J Neurochem; 1995 Jun; 64(6):2473-9. PubMed ID: 7760026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel actions of inverse agonists on 5-HT2C receptor systems.
    Berg KA; Stout BD; Cropper JD; Maayani S; Clarke WP
    Mol Pharmacol; 1999 May; 55(5):863-72. PubMed ID: 10220565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of serotonin 5-HT2C receptors by chronic ligand exposure.
    Devlin MG; Smith NJ; Ryan OM; Guida E; Sexton PM; Christopoulos A
    Eur J Pharmacol; 2004 Sep; 498(1-3):59-69. PubMed ID: 15363976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
    Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division.
    Westphal RS; Sanders-Bush E
    Mol Pharmacol; 1996 Mar; 49(3):474-80. PubMed ID: 8643087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.
    Watson J; Brough S; Coldwell MC; Gager T; Ho M; Hunter AJ; Jerman J; Middlemiss DN; Riley GJ; Brown AM
    Br J Pharmacol; 1998 Dec; 125(7):1413-20. PubMed ID: 9884068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
    Labrecque J; Fargin A; Bouvier M; Chidiac P; Dennis M
    Mol Pharmacol; 1995 Jul; 48(1):150-9. PubMed ID: 7623769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.
    Porter RH; Benwell KR; Lamb H; Malcolm CS; Allen NH; Revell DF; Adams DR; Sheardown MJ
    Br J Pharmacol; 1999 Sep; 128(1):13-20. PubMed ID: 10498829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line.
    Kelly CR; Sharif NA
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1254-61. PubMed ID: 16517693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.
    Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ
    Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-induced calcium signaling via 5-HT1A receptors in human leukemia (K 562) cells.
    Khan NA; Ferriere F; Deschaux P
    Cell Immunol; 1995 Oct; 165(1):148-52. PubMed ID: 7671319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity.
    Dunlop J; Sabb AL; Mazandarani H; Zhang J; Kalgaonker S; Shukhina E; Sukoff S; Vogel RL; Stack G; Schechter L; Harrison BL; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2005 May; 313(2):862-9. PubMed ID: 15705738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.
    Rauser L; Savage JE; Meltzer HY; Roth BL
    J Pharmacol Exp Ther; 2001 Oct; 299(1):83-9. PubMed ID: 11561066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of the serotonin-induced increase in intracellular calcium in rat aortic smooth muscle cells by sarpogrelate.
    Saini HK; Sharma SK; Zahradka P; Kumamoto H; Takeda N; Dhalla NS
    Can J Physiol Pharmacol; 2003 Nov; 81(11):1056-63. PubMed ID: 14719041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
    Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
    Br J Pharmacol; 1998 Dec; 125(7):1463-70. PubMed ID: 9884074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes.
    Shimizu M; Nishida A; Zensho H; Yamawaki S
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1551-8. PubMed ID: 8968382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.